This Week in Psychedelics - 10.8.21

Cannabis

• Philadelphia Will Vote On Marijuana Referendum Calling For Statewide Legalization Next Month (Marijuana Moment)

• Top Mexican Senator Lays Out Next Steps For National Marijuana Legalization (Marijuana Moment)

• Nevada: New Marijuana Laws Took Effect This Month (NORML)

• Portugal Delays Recreational Cannabis Bills as Luxembourg Also Signals Delay (High Times)

• New York: Regulators Approve Patients’ Access to Medical Cannabis Flower (NORML)

• NBA Won’t Randomly Drug Test Players For Marijuana For Another Season, League Announces (Marijuana Moment)

• Lung Injuries Tied To Contaminated Vapes Were Less Common In States With Legal Marijuana And Homegrow, Study Finds (Marijuana Moment)

• California Legalizes Smokable Hemp and Food Sales in Historic Bill (High Times)

• Preconception cannabis use linked to an increased risk of postpartum depression (PsyPost)

• More Than A Dozen Ohio Cities Will Vote On Marijuana Decriminalization Ballot Measures Next Month (Marijuana Moment)

• CBGA More Effective For Seizures Than CBD, Study of Mice Finds (High Times)

• Study: Cannabis Use Disorder Diagnosis Associated with Greater Risk of COVID Breakthrough Infections — NORML Responds (NORML)

• Bipartisan Pennsylvania Senators Unveil Marijuana Legalization Bill Amid Whirlwind Of Reform Efforts In The State (Marijuana Moment)

• Oklahoma Activists File Marijuana Legalization And Medical Cannabis Reform Initiatives For 2022 Ballot (Marijuana Moment)

LSD

• Inside the World’s Largest Collection of Acid Tabs (DoubleBlind)

• Acid Communism (Daniel Pinchbeck)

Magic Mushrooms

• GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders (Marijuana Moment)

• Denver may ease magic mushrooms laws further two years after decriminalization (The Denver Post)

• Is Denver’s Psilocybin Decriminalization Having an Impact? (Filter)

• Psychedelic drug changes the emotional state of people listening to music (News-Medical.net)

• "Homebrew" Psilocybin Created By Scientists Using "Widely Available" Materials (IFLScience)

• Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson (Mydecine)

• Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio (Psilocybin Alpha)

• Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1 (Psilocybin Alpha)

MDMA

• Why You Vom When You’re Coming Up On MDMA (VICE)

• MDMA-assisted psychotherapy associated with sleep improvements among PTSD patients (PsyPost)

Peyote

• Santa Cruz Removes Peyote And Other Mescaline-Containing Cacti From Psychedelics Decriminalization Law (Marijuana Moment)

Novel Psychoactive Substances

• Psychedelic Capital: Novel Psychedelic Molecules (Truffle Report)

Ketamine

• Recreational ketamine use has increased in recent years, but remains rare (Medical Xpress)

• PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

• Seattle Becomes Largest U.S. City To Decriminalize Psychedelics (Marijuana Moment)

• Arcata, California Decriminalizes Psychedelics (Truffle Report)

• The Psychedelics Industry Could Offer a Whole New Approach to Work (Rolling Stone)

• Will Smith Recalls Life-Changing Psychedelic Experiences in New Book (High Times)

• PSYCH Publishes Third Edition of The Psychedelics as Medicine Report (PR Newswire)

• Toronto’s Bid to Decriminalize Drugs Hangs in the Balance (Filter)

• The Need for New Psychedelic Compounds (Psychology Today)

• Risks of Serotonin Syndrome when Combining Psychedelics with Antidepressants (Chacruna)

• The 'Psychedelic Renaissance' Is Entirely About Corporate Greed (Caitlin Johnstone)

• Becoming a Yes-Sayer: Psychedelics, Nietzsche, and the Affirmation of Life (Sam Woolfe)

• Will Psychedelic Companies Embrace Indigenous Reciprocity? (Lucid News)

• What Is Hallucinogen-Persisting Perception Disorder (HPPD)? (PsychCentral)

• Anima Mundi: Psychedelics and The Ensouled Earth (Psychedelics Today)

• Ensuring Equity in Psychedelic Science and Businesses (Truffle Report)

• Death and psychedelics: How science is reviving this ancient connection (Leafly)

• DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t (Psymposia)

• Psychedelic-Induced Psychological Flexibility Can Reduce Racial Trauma (Truffle Report)

• Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison (Psilocybin Alpha)

• Psychedelics and Mental Health Therapy in Colorado: DORA and Potential Regulatory Response (JD Supra)

• Psychedelics and Perception Part 2: The First Era of Research (Psychedelic Science Review)

• It’s one big mistake (New Amsterdam Psychedelic Law)

• Madison Margolin Sounds Off on Mainstreaming of Cannabis and Psychedelics Cultures (CelebStoner)

• Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics 10.8.21 Will Be Delayed

Just a heads up—this week’s psychedelic news link roundup will be delayed. It will come out sometime early next week.

This Week in Psychedelics - 10.1.21

Cannabis

• Bill To Federally Legalize Marijuana Approved By Key House Committee (Marijuana Moment)

• Marijuana Arrests Fall Precipitously Nationwide in 2020 (NORML)

• California Governor Signs Bill To Allow Medical Marijuana Use In Hospitals For Severely Ill Patients (Marijuana Moment)

• Kansas City, MO: City Council Approves Measure Eliminating Pre-Employment Marijuana Testing for Most City Workers (NORML)

• Hundreds prescribed medical cannabis in bid to persuade lawmakers to offer it on NHS (Mirror)

• Mississippi Lawmakers Move to Implement Medical Cannabis Legislation (High Times)

• Los Angeles: District Attorney to Vacate Some 60,000 Marijuana Convictions (NORML)

• DEA Still Insists Marijuana Has No 'Accepted Medical Use' (Reason)

• The Making Of New York’s $150 Million ‘Cannabis Campus’ (Forbes)

• What are they smoking? CNN says study found cannabis could double heart attack risk – but did it? (The Cannigma)

• Pennsylvania Lawmakers Unveil Marijuana Legalization Bill With Focus On Social Equity (Marijuana Moment)

• Your Smartphone Can Tell If You’re High On Marijuana, Study Finds (Forbes)

• Nebraska Advocates Launch Signature Drive For 2022 Medical Marijuana Ballot Measures (Marijuana Moment)

• Curbside Recreational Weed Pickups End in Massachusetts (High Times)

• Federal Grant Approved to Study Medical Marijuana Impact in Arkansas (High Times)

LSD

• Cannot treat LSD and its carrier material as separate, says court Cannot treat LSD and its carrier material as separate, says court (The Times of India)

Magic Mushrooms

• From Sugar To Psychedelics: The European Companies Testing Biosynthetic Psilocybin In Humans (Forbes)

• Decrim California’s Plan to Regulate Psilocybin Via Ballot (Truffle Report)

• My Bipolar Mother's Quest For Relief With Magic Mushrooms (VICE)

• Oregon Board to Vote on Psilocybin Facilitator Program (Truffle Report)

• Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing (Psilocybin Alpha)

MDMA

• MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy (Psilocybin Alpha)

• Levels of MDMA and cocaine in river running through Glastonbury Festival site so high they could harm wildlife, scientists say (Independent.ie)

• Police urging parents to inspect Halloween candy after ecstasy discovered (Fox News)

• MDMA: A Catalyst for ED-PTSD Treatment (Psychedelic Science Review)

DMT

• Companies Compete to Create DMT Therapies (Lucid News)

Ayahuasca

• Will Smith Embarked On A Dozen Ayahuasca Rituals In Peru After Denzel Washington Sold Him On The “F*ck It 50s” (BroBible)

• Man charged after alleged sex assault linked to ayahuasca ceremony (CBC)

Novel Psychoactive Substances

• Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders (Psilocybin Alpha)

• BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders (Psilocybin Alpha)

• Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates (Psilocybin Alpha)

Ketamine

• Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate (News-Medical.net)

Miscellaneous

• Ending The Silence Around Psychedelic Therapy Abuse (Mad in America)

• Can Psychedelic Drugs Treat Physical Pain? (Scientific American)

• Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre (Psilocybin Alpha)

• Seattle City Council Takes First Step Toward Decriminalizing Psychedelic Plants And Fungi (Marijuana Moment)

• Florida Lawmakers Introduce Bill to Study Psychedelics (Truffle Report)

• DoubleBlind Magazine's First-Ever Psychedelics Billboard Campaign Is Turning New Yorkers On To Plant Medicine (Benzinga)

• Psychedelics might reduce internalized shame and complex trauma symptoms in those with a history of childhood abuse (PsyPost)

• Massachusetts Lawmakers Discuss Drug Decriminalization And Safe Injection Sites At Hearing (Marijuana Moment)

• Bay Staters for Natural Medicine on Easthampton Decrim (Truffle Report)

• ‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health (The Guardian)

• Are Psychedelic Drugs the Answer to Veterans’ PTSD? (Men's Health)

• 19-Year-Old New Hampshire Lawmaker Prepares Bills To Decriminalize Psilocybin And All Drugs (Marijuana Moment)

• Elon Musk Embraces Potential of Psychedelics at CodeCon (High Times)

• How Effective Is Fireside Project's Psychedelic Hotline? New Study Aims To Find Out (Forbes)

• Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality (Psychedelics Today)

• Pantheistic Insights: Vegetarianism in Psychedelic Culture (The Oak Tree Review)

• 'The End In Mind' Conference Answers Questions About Psychedelics For End-Of-Life Patients (Forbes)

• Community Alert! Arrests and Encounters with Law Enforcement are Increasing (Chacruna)

• People Are Facing Legal Repercussions for Serving Plant Medicine — Here’s What’s Being Done to Help Them (DoubleBlind)

• Does psychedelic microdosing work? Brain study will be the real acid test (The New Daily)

• Psychedelia in the Soviet Union (Reality Sandwich)

• The Mystical Experience Defines Psychedelics (Lucid News)

• Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases (PR Newswire)

• Why Psychedelic Therapy Needs Best Practices & How to Get There (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - September 2021

September was another busy month in the world of psychedelics. Some of the highlights include Hamilton Morris ending his show and joining a notorious psychedelic company, the FDA and CDC issuing scary warnings about delta-8 THC products, Scotland decriminalizing all drugs, the looming threat that nitrous oxide might become illegal in the UK soon, and a study finding that young adults are using a lot of psychedelics during the pandemic.

Here’s a video version of this month’s recap if you’d prefer to watch the update instead:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Policy

Wins

Every month activists and politicians work feverishly toward reforming drug policies all over the world, and this month was no exception. Among some of the victories, the possession of Class A drugs is now set to be effectively decriminalized in Scotland, which means people who are caught with substances like MDMA and LSD will be given a warning instead of facing prosecution.

A recreational cannabis trial in Zurich is slated to begin in 2022. The Swiss pilot program will run for three-and-a-half years and may influence other European countries to follow suit.

Future

There are several drug policy bills and initiatives coming down the pike. Michigan has multiple efforts to decriminalize psychedelics, including Senate Bill 631, which would decriminalize the possession and use of many psychedelics across the state, and there are also local efforts to decriminalize psychedelics in Detroit, Grand Rapids, and Hazel Park.

Meanwhile, authorities in the UK are so concerned about the trash that is generated from public nitrous oxide use that they’re pushing to ban the drug outright.

Just a couple months after the suspension of runner Sha’Carri Richardson from competing in the Olympics due to a positive THC test, the World Anti-Doping Agency is going to conduct a scientific review of cannabis next year to figure out whether to continue the international ban of marijuana use by athletes.

Industry

If you haven’t already heard of him, Hamilton Morris is a very well-known figure in the world of psychedelics. He’s a research scientist, journalist, and filmmaker who gave the world the brilliant TV show Hamilton’s Pharmacopeia, which explores the chemistry, history, and cultural impact of various psychoactive drugs.

However, his show is coming to an end after three seasons, as he has been hired as a full-time consultant for COMPASS Pathways, the mental healthcare company notoriously attempting to profit off of medicalizing psilocybin.

Research

Published Studies

The annual Monitoring the Future survey looked at the recreational use of psychedelics by young people and found that it is on the rise in the United States. This increase in psychedelic exploration by U.S. college students and other young adults has risen in part because of the COVID-19 pandemic but also because psychedelics are more accepted today than they used to be.

Yale researchers found that a single dose of psilocybin can promote structural changes in the brains of mice that fight against symptoms of depression. The scientists discovered that psilocybin triggered a 10% increase in neuron size and density in the animals’ frontal cortex, which occurred within 24 hours and lasted for one month, indicating that psilocybin engendered long-lasting changes in the brain.

A first-of-its-kind study published in Psychopharmacology found that synthetic cannabinoid users experience more severe withdrawal symptoms than traditional cannabis users. During a period of abstinence, adverse side effects like insomnia, irritation, moodiness, heart palpitations, and appetite were significantly worse in the synthetic cannabis-using group.

Future Studies

Looking ahead, a study looking to treat tobacco addiction with psilocybin will receive federal funding from the National Institute on Drug Abuse, making this the first time an investigation into the potential therapeutic effects of psychedelics has received funds from the federal government since the War on Drugs began in the 1970s.

Researchers at the University of California San Francisco will determine how effective Fireside Project’s psychedelic hotline and app actually are at helping people navigate their psychedelic experiences.

A study has been given the fitting name of “Desire Project” because it will look at treating female hypoactive sexual desire disorder with MDMA-assisted psychotherapy.

The first participant in a psilocybin trial for a rare headache disorder named short-lasting unilateral neuralgiform headache attacks (SUNHA) received an initial low dose of the drug to kick off the study. The disorder involves short, incredibly painful headaches that can occur many times a day, and there are not currently any approved treatments for it. This proof-of-concept Phase 1B trial will enroll 12 patients and is expected to generate results in early 2022.

The Heroic Hearts Project UK announced a study with Imperial College London that will investigate the physiological and psychological effects of psilocybin on veterans with traumatic brain injury. The researchers hope to add additional weight to the mostly anecdotal body of evidence suggesting that the drug may help people heal from this sort of ailment.

Harm Reduction

The FDA and CDC issued warnings to consumers about potential risks involving delta-8 THC, a relatively new psychoactive cannabinoid that has grown in popularity due to its widespread legality but remains essentially unregulated at this time. Apparently there has been a significant increase in reported adverse health effects from people using this drug.

However, before you go ahead and toss any of these products you may already own out of the window, it may be helpful to know that it’s not like people are getting poisoned. In fact, it’s far more likely that they are unintentionally getting high after using delta-8 THC because of misunderstandings, bad labeling, and a lack of experience.

Miscellaneous

Following up on the case involving the death of unarmed 23 year-old Elijah McClain after being administered a fatal dose of ketamine by first responders in Aurora, Colorado back in 2019, the police officers and paramedics involved have all been charged with criminally-negligent homicide and manslaughter.

New forensic science techniques have been developed that will enable law enforcement agencies to recover human DNA from the surfaces of pills and capsules, which authorities hope will help them identify who has handled illicit substances that are seized by police. This means that anyone touching an MDMA capsule or ecstasy pill for as little as 15 seconds during their production, assembly,  or distribution could be identified using this new technology.

A new Hulu show called Nine Perfect Strangers is the latest mainstream production to feature psychedelic use, and apparently it’s fairly problematic. I haven’t watched it yet myself but from what I’ve read, the plot involves a wellness guru who runs a retreat where she gives attendees microdoses of psilocybin without their knowledge or consent. It should go without saying that this is not cool and dosing others without them knowing it is unethical and potentially extremely dangerous. I’m going to reserve any judgment on this show until I make time to check it out myself, but now you’ll have at least a little bit of an idea about it in case anyone you know mentions it to you.

There is an update on the story involving Jake Angeli, AKA the “QAnon Shaman” who participated in the storming of the U.S. Capitol on January 6th of this year. Earlier this month Angeli plead guilty to one of the most serious of his six charges and could face a maximum of 20 years in prison, although his lack of a criminal record will likely mean he will serve much less time.

The ongoing global labor shortage means that employers around the world are finding it difficult to hire employees, and screening them for drug use is making things even harder. As a result, many companies are getting rid of drug tests in an effort to attract more applicants, fill vacancies, and keep their existing workers.

Hiring wasn’t the only thing that was impacted during the pandemic—it turns out that cannabis arrests in the U.S. declined significantly during 2020, according to data released by the FBI. Still, more than 350k marijuana-related arrests were made last year, mostly in states that have not yet decriminalized or legalized possession and use of the plant.

Wrapping up this month’s recap is a story out of Canada where a group of drug users and drug policy reformers are so fed up with the drug war that they are suing the government. The non-profit organization is known as the Canadian Association of People Who Use Drugs and they are claiming that the Canadian government is responsible for fatal overdoses because it requires users to go to the illegal market and purchase unsafe drugs from a toxic drug supply.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 9.24.21

Cannabis

• Switzerland’s Zurich to Begin Recreational Cannabis Trial in 2022 (High Times)

• U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote (High Times)

• Green Party in Finland Calls for End of Prohibition (High Times)

• This company is smuggling tons of legal cannabis into streets, whistleblower alleges (Leafly)

• California State Fair Will Host Marijuana Competition For The First Time At 2022 Event, Officials Announce (Marijuana Moment)

• Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week (NORML)

• Rhode Island Lawmakers Are ‘Very Close’ On Marijuana Legalization Deal Ahead Of Possible Special Session, Top Senator Says (Marijuana Moment)

• Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble (Lucid News)

• Pennsylvania Senators Discuss Bill To Provide DUI Protections For Medical Marijuana Patients (Marijuana Moment)

• VA sending mixed messages for vets about cannabis use to treat PTSD (Arizona Mirror)

• Delaware: Governor Signs Measure Amending Cannabis Penalties for Minors (NORML)

• FBI Clarifies That Using Marijuana More Than 24 Times Disqualifies Would-Be Agents (Marijuana Moment)

• Former Massachusetts Mayor Sentenced for Extortion (High Times)

• Controlling cannabis and the classification of Delta-8 THC (Reuters)

• Eaze launches California program to bring free medical cannabis to low-income patients (Greenway Magazine)

• Mississippi Lawmakers Reach Deal On Medical Marijuana Legalization, Plan To Request Special Session (Marijuana Moment)

• For Chronic Pain Sufferers, Cannabis "May Be a Source of Hope" (Green Entrepreneur)

• Full-Page Washington Post Ad Calls For Marijuana Prisoner’s Freedom While Celebs Make Money In Industry (Marijuana Moment)

• Can Cannabis Help Your Gut? (TIME)

• Florida Marijuana Activists File New Legalization Initiative For 2022 Ballot Following Supreme Court Defeats (Marijuana Moment)

• Oklahoma Activists Finalize Language For Two 2022 Marijuana Ballot Initiatives (Marijuana Moment)

• Nebraska Cannabis Association launches as state's first lobbying group for marijuana-based businesses (York News-Times)

Magic Mushrooms

• Psilocybin Study for Tobacco Gets Federal Funding (Truffle Report)

• Thousands attend first-ever psychedelic shroom festival in Ann Arbor (MLive.com)

• Canadian Coalition Submits Draft for Legal Psilocybin Therapy (Truffle Report)

• Happy Global Magic Mushroom Day (9/20) for Psilocybin Fans (CelebStoner)

• Nine Perfect Strangers's Portrayal of Psilocybin Could Derail Progress in Researching Psychedelic Use for Mental Health (Teen Vogue)

• Shroom Delivery is Now a Thing (DoubleBlind)

• Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac (Newsweek)

• Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism (Marijuana Moment)

• Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 (Psilocybin Alpha)

• Amanita muscaria – A Fresh Look at An Iconic Mushroom (Psychedelic Science Review)

• The 25 Best U.S. Counties for Mushroom Foragers (moveBuddha)

• MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration (Psilocybin Alpha)

• Eversio Wellness Harvests Its First Legally Grown Psychoactive Mushrooms (Yahoo! Finance)

MDMA

• Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London (Psilocybin Alpha)

DMT

• Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy (Psilocybin Alpha)

5-MeO-DMT

• I Wanted Ego Death. This Powerful Psychedelic Gave It To Me. (BuzzFeed News)

• Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT (TheNewswire)

Mescaline

• Mescaline, Veganism, and Schopenhauer’s Philosophy (Sam Woolfe)

Iboga

• DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder (Psilocybin Alpha)

Salvia Divinorum

• Salvia Divinorum and Kratom Combination – What You Must Know About It (IRN Post)

Novel Psychoactive Substances

• Are Prodrugs the Next Wave of Psychedelic Drug Development? (Psychedelic Science Review)

• Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018 (Psilocybin Alpha)

• Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders (Psilocybin Alpha)

• Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug (Yahoo! Finance)

• Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data (Psilocybin Alpha)

Synthetic Cannabinoids

• Spice is significantly more harmful than marijuana (International Business Times)

• New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol (Yahoo! Finance)

Nitrous Oxide

• TikTok Is Hosting Ads for ‘Whipped Cream’. But It’s Actually Nitrous Oxide (VICE)

Ketamine

• Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S. (Canadian Lawyer)

• Turning Everyday Therapist Offices into Ketamine Clinics (Lucid News)

• Statistical model defines ketamine anesthesia’s effects on the brain (MIT News)

• Is A Ketamine Infusion Covered By Insurance? (Healing Maps)

Miscellaneous

• Companies are Getting Rid of Drug Tests Because They Can’t Find Enough Workers (VICE)

• Class A drug possession ‘effectively decriminalised’ in Scotland (The Times)

• Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice (Psymposia)

• Italian Advocates Collect 500,000 Signatures for Decriminalization of Cannabis and Psychoactive Substances (High Times)

• Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It (VICE)

• Meet Microdosing TikTok—And Why the Community Matters (Psychedelics Today)

• More Michigan Cities Look to Decriminalize Psychedelics (Truffle Report)

• The Michigan Poison and Drug Information Center issues notification about effects and risks of using psychedelic substances (Today@Wayne)

• Criticism of Awakn Treatment Model as Second Clinic Opens for Treating Addiction (TalkingDrugs)

• Psychedelic Patents: Nature, IP Law, & Exclusion (Truffle Report)

• How To Come Down From A High: Navigating the Downslope of a Trip (DoubleBlind)

• Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery (Forbes)

• Psychedelic Water founder looks to new legal era for powerful drugs (The Washington Times)

• Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies (Psilocybin Alpha)

• Why Bristol Uni is taking a more progressive stance on drugs (The Bristol Cable)

• Numinus Completes Acquisition of Neurology Centre of Toronto (Psilocybin Alpha)

• The Removal of the Ecuadorian Drug Possession Table: A Major Government Mistake (TalkingDrugs)

• ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.